Number of shares of equity interests issued or issuable to acquire entity.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 805
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(4)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479581/805-30-50-1

+ Details

Name:	us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 944
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(15)(a))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.15(5))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1

+ Details

Name:	us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

The highest quantity of shares an employee can purchase under the plan per period.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

The amount of aggregate net revenue that must be satisfied to issue the full amount of equity.

+ References

No definition available.

+ Details

Name:	ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableAggregateNetRevenueCriteria
Namespace Prefix:	ycbd_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Represents the additional shares issued or issuable for business acquisition.

+ References

No definition available.

+ Details

Name:	ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfAdditionalEarnoutShares
Namespace Prefix:	ycbd_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Represents the expiration period for additional shares issuable.

+ References

No definition available.

+ Details

Name:	ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfAdditionalEarnoutSharesExpiration
Namespace Prefix:	ycbd_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Represents the vesting period of issued and/or issuable shares issued for acquisition.

+ References

No definition available.

+ Details

Name:	ycbd_BusinessAcquisitionEquityInterestIssuedOrIssuableVestingPeriod
Namespace Prefix:	ycbd_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	instant

- Definition

Minimum consumer revenue required for share-based compensation arrangement.

+ References

No definition available.

+ Details

Name:	ycbd_SharebasedCompensationArrangementBySharebasedPaymentAwardMinimumConsumerRevenueRequired
Namespace Prefix:	ycbd_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Details

Name:	us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AwardTypeAxis=ycbd_EmployeeStockOptionsAndRestrictedStockUnitsRsusMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=ycbd_CureBasedDevelopmentLlcMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementClassOfStockAxis=ycbd_RegisteredCommonStockMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementClassOfStockAxis=ycbd_UnregisteredCommonStock2Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementClassOfStockAxis=ycbd_UnregisteredCommonStockMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Note 6 - Contingent Consideration (Details Textual) - USD ($) $ in Thousands			1 Months Ended			3 Months Ended	9 Months Ended
	Apr. 30, 2019	Dec. 20, 2018	Nov. 30, 2023	Dec. 31, 2022	Apr. 30, 2019	Dec. 31, 2022	Jun. 30, 2022	Sep. 30, 2023	Apr. 30, 2022
Share-Based Payment Arrangement, Option [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Number of Shares Per Employee (in shares)				556
Restricted Stock Units (RSUs) [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Number of Shares Per Employee (in shares)				556
Employee Stock Options and Restricted Stock Units (RSUs) [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Minimum Consumer Revenue Required				$ 45,000
Employee-related Liabilities, Total								$ 0
Cure Based Development, Llc [Member] \| Common Stock [Member]
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares)					338,889		271,405
Business Acquisition, Equity Interest Issued or Issuable, Vesting Period (Year)									5 years
Business Acquisition, Equity Interest Issued or Issuable, Number of Additional Earnout Shares (in shares)			19,818		338,889
Business Acquisition, Equity Interest Issued or Issuable, Number of Additional Earnout Shares, Expiration (Month)		60 months			60 months
Business Acquisition, Equity Interest Issued or Issuable, Aggregate Net Revenue Criteria			$ 35,800
Cure Based Development, Llc [Member] \| Registered Common Stock [Member]
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares)					144,445
Cure Based Development, Llc [Member] \| Unregistered Common Stock 2 [Member]
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares)					194,945
Cure Based Development, Llc [Member] \| Unregistered Common Stock [Member]
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares)	194,445				194,445
Business Acquisition, Equity Interest Issued or Issuable, Vesting Period (Year)	5 years				5 years
Business Acquisition, Equity Interest Issued or Issuable, Number of Additional Earnout Shares (in shares)						338,889